ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007

USPSTF Delivers “D” Recommendation For Ovarian Cancer Screening

September 28, 2012

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

In Brief: Bast To Head M.D. Anderson Medicine Dib.; Ozer Named Emory Cancer Center Director

April 8, 1994

NCI Programs: Four Awarded Grants For Chem-Bio Centers; NCI To Commit $20M For Cancer Informatics Infrastructure

October 23, 1998